COMMUNIQUÉS West-GlobeNewswire

Zealand Pharma: Transactions related to share buy-back program (week 29, 2026)
20/07/2026
Company announcement No. 33 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 29, 2026) Copenhagen, Denmark, July 20, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: [...]
La Cour suprême du Canada confirme l’interdiction des brevets sur les traitements médicaux
20/07/2026
MONTRÉAL, 20 juill. 2026 (GLOBE NEWSWIRE) -- La Cour suprême du Canada a rendu sa décision très attendue dans l’affaire Pharmascience Inc. c. Janssen Inc. , qui porte sur la validité du brevet de Janssen relatif au [...]
Route 92 Medical Celebrates the 200th Patent for its Neurovascular Intervention Portfolio
20/07/2026
New global patents protect Route 92 Medical’s ongoing innovation as the company works to address critical unmet needs in neurovascular treatment WEST JORDAN, Utah, July 20, 2026 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc [...]
A Father's Gift, A World First: Six-Year-Old Becomes First Patient to Receive a Liver Transplant Through a Single Robotic Incision
20/07/2026
RIYADH, Saudi Arabia, July 20, 2026 (GLOBE NEWSWIRE) -- A father's decision to give part of his liver to save his son has resulted in a global medical first. King Faisal Specialist Hospital and Research Centre (KFSH) [...]
Virbac: solid growth of +7.4% at CERS in H1 2026, fueled by double-digit growth of our Supercharge4 platforms
20/07/2026
First half 2026 revenue reached €768m : +7.4% at constant exchange rate and scope (CERS) vs H1 2025 +4.0% at actual rates impacted by currency headwinds Balanced growth in both segments : companion animal +10.0% and [...]
New resources on the way for BC farms under pressure from pests and disease
20/07/2026
VANCOUVER, British Columbia, July 20, 2026 (GLOBE NEWSWIRE) -- British Columbia is home to a prolific fruit and vegetable production sector, satisfying local consumers and exporting $1.2 billion in products to markets [...]
Supreme Court of Canada Upholds Prohibition on Medical Treatment Patents
20/07/2026
MONTREAL, July 20, 2026 (GLOBE NEWSWIRE) -- The Supreme Court of Canada released its highly anticipated decision in Pharmascience Inc. v. Janssen Inc. , which addresses the validity of Janssen’s patent relating to the [...]
Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion
20/07/2026
● As of July 18, 2026, net asset value (NAV 1 ) per share was $66.16 ● As of July 18, 2026, Enlivex held 79,550,593,122 RAIN tokens with a total value of approximately $1.1 billion 2 . Nes-Ziona, Israel, July 20, 2026 ( [...]
Standard BioTools Announces Filing of Registration Statement in Connection with Treeline Biosciences Transaction
20/07/2026
Highlights combined company’s strong financial position with over $900 million expected at closing, Treeline’s deep clinical-stage pipeline, planned 2027 data updates for TLN-121 and TLN-372, and expected new program [...]
Clearmind Medicine Expends Global IP portfolio with Hong Kong Patent Filing for Novel Psychedelic Compounds; Targets Multi‑Billion‑Dollar PTSD Therapeutics Market
20/07/2026
Vancouver, Canada, July 20, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (“ Clearmind ”) (Nasdaq: CMND), a clinical-stage biotechnology company pioneering nonhallucinogenic neuroplastogen - derived treatments for [...]
Xanamem proof-of-concept trial demonstrating anti-depressant activity published in the British Journal of Psychiatry
20/07/2026
Ongoing Xanamem (emestedastat) Alzheimer’s disease pivotal trial progresses toward final results in November this year SYDNEY, July 20, 2026 (GLOBE NEWSWIRE) -- Actinogen Medical Limited (ASX: ACW) today announces that [...]
Dogwood Enrolls First 200 Patients in Ongoing Halneuron® Phase 2b Chemotherapy Induced Neuropathy Trial; Top-line Data Expected in Fall 2026
20/07/2026
- Continued low early termination rate (4.5%) among the first 200 patients enrolled in the study suggests Halneuron® and placebo treatment have been well tolerated - ATLANTA, July 20, 2026 (GLOBE NEWSWIRE) -- Dogwood [...]
ORIC® Pharmaceuticals Announces Three Presentations at the European Society for Medical Oncology (ESMO) Congress 2026
20/07/2026
Enozertinib poster presentation to highlight data from an ongoing Phase 1b trial in first-line EGFR atypical NSCLC Rinzimetostat trial-in-progress poster presentation to highlight the ongoing Himalayas-1 Phase 3 study [...]
Novo Nordisk A/S - share repurchase programme
20/07/2026
Bagsværd, Denmark, 20 July 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) [...]
MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29
20/07/2026
MARIETTA, Ga., July 20, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the second quarter ended June 30 [...]
Monopar Advances Launch Readiness with Addition of Veteran Commercial Executive Nicole Sweeny to Board of Directors and Expansion of Commercial Leadership Team
20/07/2026
WILMETTE, Ill., July 20, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with [...]
University of Szeged Pioneers First Robotic Cardiology Program in Hungary
20/07/2026
First Robotic Magnetic Navigation system installed in Hungary University of Szeged, led by Cardiology Chief Dr. Szili-Torok, expected to treat hundreds of patients annually with all forms of cardiac arrhythmia using [...]
Dyne Therapeutics Announces U.S. FDA Acceptance of Biologics License Application (BLA) for Z-Rostudirsen in Exon 51 Duchenne Muscular Dystrophy (DMD)
20/07/2026
- Priority Review granted; PDUFA target action date set for January 21, 2027 - - Submission for Accelerated Approval based on dystrophin as a surrogate endpoint - - In the registrational expansion cohort of the DELIVER [...]
DLH to Announce Fiscal 2026 Third Quarter Financial Results
20/07/2026
ATLANTA, July 20, 2026 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital [...]

Pages